share_log

Ascensis Pharma Says FDA Will Review Application for Adult Treatment of Growth Hormone Deficiency

Ascensis Pharma Says FDA Will Review Application for Adult Treatment of Growth Hormone Deficiency

Ascensis Pharma表示,美国食品和药品管理局将审查成人生长激素缺乏症治疗的申请
WSJ ·  2024/12/12 14:21

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发